NOT KNOWN FACTUAL STATEMENTS ABOUT SEMAGLUTIDE WEEK 1-6 BUNDLE

1) and Drug Interactions (seven)]. The risk of hypoglycemia could be reduced by a reduction from the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Inform patients utilizing these concomitant drugs of the potential risk of hypoglycemia and teach them about the symptoms and signs or symptoms of hypoglycem